Overview

Infection Control Market Introduction

Infection Control Market to value over US $ 26 billion and register a CAGR of over 6% during the forecast period of 2020-2027.

The rise in geriatric population along with the widening prevalence of chronic diseases due to lifestyle changes, sedentary habits, unhealthy dietary routines will drive future market growth. The population is thus more prone to acquiring infections due to the presence of a combination of increased comorbid condition and decreasing efficiency of the immune system.

The increasing frequency of surgical procedures coupled with the growing incidence of nosocomial infections will boost infection control market growth during the forecast period. Considering the statistics by WHO, 10 out of every 100 individuals hospitalized globally in developing countries and 7 in developed countries are likely to acquire nosocomial infections. The statistics accurately reflect the swelling need for the market’s products and services.

The market is classified into products & services, end-users, and region. In the products and services segment, the market is anticipated to grow at a lucrative rate throughout the forecast period. This accelerated increase is attributed to the high affinity of market players to diminish overall healthcare expenditure along maximizing patient benefits.

In context to end-users, hospitals and clinics held a principal share and are predicted to achieve growth at the highest CAGR throughout the forecast period. The substantial share is majorly a consequence of high probability of acquiring infections in hospital premises through respiratory or bloodborne pathogen transmission.

Based on the region, the Asia Pacific market is presumed to register the fastest growth during the projected time period with the surge in healthcare expenditure and superlative healthcare standards and infrastructure. Boost in the number of outsourcing organizations in the region will benefit the market in the forthcoming years. A voluntary organization, Asia Pacific Society of Infection Control (APSIC) entertains collaborations and partnerships as well as infection control research to promote cost-efficient practices throughout the region. The regional market also gains momentum on the back of various government organizations committed to elevating the standards for infection control.

Impact of COVID-19 on Infection Control Market:

According to WHO, the transmission of the COVID-19 is through respiratory droplets, i.e. droplets that are larger than 5 micrometers of diameter, and through contact route. With countries like India going under complete lockdown, the transmission of infection shall be curbed down significantly. Furthermore, hospitals are providing optimum healthcare services like creation of isolation wards for the infected patients, using PPE kits to treat the infected patients whilst avoiding getting infected. They also use EPA-certified surface disinfectants to clean the hospital premises.

Major industry players include:

3M Company, Belimed, Ahlstrom Corporation, Johnson & Johnson, Sterigenics International, Kimberly Clark Corporation, Steris, Getinge Group, Matachana Group, Cantel Medical Corporation.

Infection Control Market

Competitive Landscape:

The major market players adopt strategies of mergers, acquisitions, and new product launches in order to strengthen their market position and establish a global foothold in the market
Nelson Laboratories, a division of Sotera Health (US), acquired Gibraltar Laboratories (US). This strengthened the portfolio of infection control test services for pharmaceutical and medical device manufacturing companies
Cantel Medical (US) launched ADVANTAGE PLUS Pass-Thru Automated Endoscope Reprocessor, which thus expanded the market and product portfolio
Sotera Health (US) signed an agreement with Noxilizer (US), which gave Sterigenics the exclusive rights for the worldwide distribution of NO2 contract sterilization products and services to the pharmaceutical, biotechnology, and medical device manufacturing industries

Infection Control Market Segmentation

By Product and Service

Sterilization Products and Services
Sterilization Equipment
Contract Sterilization Services Market
Consumables and Accessories
Cleaning and Disinfection Products
Disinfectants
Cleaning and Disinfection Equipment
Lubricants and Cleaning Solutions
Disinfection and Cleaning Accessories
Protective Barriers
Medical Nonwovens
Covers and Closures
Goggles
Endoscope Reprocessing Products
Endoscope Reprocessing Consumables
Endoscope Reprocessing Equipment
Other Endoscope Reprocessing Products
Other Infection Control Products

By End-User

Hospitals & Clinics
Medical Device Companies
Pharmaceutical Companies
Life Sciences Industry
Food Industry
Other End Users

By Region

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

Objectives of the Study:

To provide with an exhaustive analysis on the global infection control market by product & services, by end-user, and by region
To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
To evaluate and forecast micro-markets and the overall market
To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
Profiling of companies to evaluate their market shares, strategies, financial and core competencies

Flexible Delivery Model:

We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
The customization services offered are free of charge with purchase of any license of the report.
You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com